- Home
- SBFM vs TECH Comparison
SBFM vs TECH Comparison
Compare SBFM & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- TECH
- Stock Information
- Founded
- SBFM 2006
- TECH 1976
- Country
- SBFM United States
- TECH United States
- Employees
- SBFM N/A
- TECH N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBFM Health Care
- TECH Health Care
- Exchange
- SBFM Nasdaq
- TECH Nasdaq
- Market Cap
- SBFM 4.9M
- TECH 8.0B
- IPO Year
- SBFM N/A
- TECH 1989
- Fundamental
- Price
- SBFM $1.39
- TECH $50.50
- Analyst Decision
- SBFM Strong Buy
- TECH Buy
- Analyst Count
- SBFM 1
- TECH 8
- Target Price
- SBFM $15.00
- TECH $81.14
- AVG Volume (30 Days)
- SBFM 4.4M
- TECH 2.3M
- Earning Date
- SBFM 05-19-2025
- TECH 05-07-2025
- Dividend Yield
- SBFM N/A
- TECH 0.63%
- EPS Growth
- SBFM N/A
- TECH N/A
- EPS
- SBFM N/A
- TECH 0.98
- Revenue
- SBFM $34,874,283.00
- TECH $1,196,016,000.00
- Revenue This Year
- SBFM $192.48
- TECH $8.19
- Revenue Next Year
- SBFM N/A
- TECH $8.61
- P/E Ratio
- SBFM N/A
- TECH $51.54
- Revenue Growth
- SBFM 44.75
- TECH 4.46
- 52 Week Low
- SBFM $1.17
- TECH $46.44
- 52 Week High
- SBFM $33.60
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- SBFM 38.67
- TECH 41.82
- Support Level
- SBFM $1.17
- TECH $49.15
- Resistance Level
- SBFM $1.59
- TECH $51.53
- Average True Range (ATR)
- SBFM 0.16
- TECH 2.64
- MACD
- SBFM 0.04
- TECH 0.44
- Stochastic Oscillator
- SBFM 51.28
- TECH 54.03
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.